Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04875364 · ClinicalTrials.gov registry record · Phase 2
Do Endotypes Predict Response and Sequelae in OSA Patients
A Phase 2 study of Obstructive Sleep Apnea and Sleep, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04875364 is a Phase 2 study of Obstructive Sleep Apnea and Sleep that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 200 participants, roughly in line with the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT04875364, a Phase 2 study of Obstructive Sleep Apnea and Sleep, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate why some people have Obstructive Sleep Apnea (OSA) and how the underlying cause may relate to OSA manifestations (including sleepiness and high blood pressure) and response to different therapeutic approaches (ie CPAP, eszopiclone, and supplemental oxygen). Understanding why someone has OSA could affect how best to treat that individual, but may also have an impact on what problems the disease might cause.
Conditions Studied
Interventions
- DRUG Eszopiclone
- OTHER Supplemental Oxygen
- DEVICE Continuous Positive Airway Pressure (CPAP)
Study Locations (1)
California
- Altman Clinical and Translational Research Institute Building - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2027-01-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04875364
The ClinicalTrials.gov registry entry for NCT04875364 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 3 interventions - of which Eszopiclone is the first listed.
NCT04875364 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04875364 about?
NCT04875364 is a clinical study titled "Do Endotypes Predict Response and Sequelae in OSA Patients". This study will investigate why some people have Obstructive Sleep Apnea (OSA) and how the underlying cause may relate to OSA manifestations (including sleepiness and high blood pressure) and response to different therapeutic approaches (ie CPAP, eszopiclone, and supplemental oxygen). Understanding ...
What is the current status of trial NCT04875364?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2020-08-01. Estimated completion is 2027-01-01.
What conditions does trial NCT04875364 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Sleep, Sleep Apnea, Obstructive, Sleep Apnea, Sleep Disorder.
What interventions are being tested in trial NCT04875364?
The interventions under investigation include: Eszopiclone (DRUG), Supplemental Oxygen (OTHER), Continuous Positive Airway Pressure (CPAP) (DEVICE).
Who is sponsoring clinical trial NCT04875364?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04875364 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
RECRUITING · Phase 2
-
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
RECRUITING · Phase 2
-
Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome
RECRUITING · Phase 2
-
Down Syndrome Obstructive Sleep Apnea
RECRUITING · Phase 2
-
Dexmedetomidine Versus Propofol Sedation for Drug-Induced Sleep Endoscopy in Pediatric Obstructive Sleep Apnea
RECRUITING · Phase 2
-
Endotypic Traits and Obstructive Sleep Apnea Surgery
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.